Secure your family's future health with Cordlife Stem Cell banking. Visit now to earn more about umbilical cord blood banking and cord lining banking.

Metascreen^™ is a non-invasive, early detection test specially designed to screen more than 100 inherited metabolic disorders in newborns.

Genetic testing uses laboratory techniques to identify possible presence of genetic diseases or gene mutations associated with increased risk of developing certain medical conditions.

From a simple blood draw as early as 10 weeks into your pregnancy, NICE® screens for the most common chromosomal abnormalities that can affect your developing baby's future. This test is done with little or no risk to your pregnancy.

A safe and highly accurate NIPT performed to screen for the most common chromosomal abnormalities such as Down syndrome. The test is done through a simple blood draw as early as 10 weeks into your pregnancy